Study of micro-invasive glaucoma surgery options
Part of Eyes & vision clinical trials.
This trial studies outcomes after certain minimally invasive glaucoma surgeries, including the Preserflo microshunt. It may help improve how safely and effectively glaucoma surgery is done, and how patients are followed afterward.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older when you sign the consent form (no maximum age).
- You are planning to get a Preserflo microshunt, trabeculectomy, or another minimally invasive glaucoma surgery.
- You can reasonably cooperate during eye tests and study visits.
- You are willing to take part and can understand and sign informed consent.
- You do NOT have glaucoma caused by bleeding, injury/trauma, inflammation in the eye (uveitis-related), or high pressure from increased fluid pressure in the veins around the eye.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two types of eye surgery to lower pressure in the eye from glaucoma. It aims to find which surgery works better for people having their first glaucoma operation.
This trial tests a tiny implant called MINIject S+ to lower eye pressure in people with open angle glaucoma that isn't well controlled with eye drops. It may be done alone or with cataract surgery.
This trial tests a new suture method during glaucoma surgery with the Preserflo device to reduce the risk of low eye pressure after the operation. It may help people with certain types of glaucoma who need surgery because their eye pressure is not controlled by medications.
This study looks at whether two types of tiny drainage stents (PreserFlo and XEN) work safely to lower eye pressure in glaucoma. Some patients will also receive an amniotic membrane (a thin tissue that helps healing) during the surgery, and researchers will compare outcomes.
This trial is checking how well a combined eye surgery (Hydrus microstent plus canaloplasty plus cataract surgery) works over 3 years. It looks at long-term safety and effect on eye pressure. It's for people with open-angle glaucoma who already had that specific combination of procedures.
This study compares three different tissues used to cover the tiny drainage device implanted during glaucoma surgery to prevent scarring. It aims to find which tissue works best to keep eye pressure low over time.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.